Free Trial
OTCMKTS:CXRXF

ADVANZ PHARMA (CXRXF) Stock Price, News & Analysis

ADVANZ PHARMA logo
$17.06
0.00 (0.00%)
(As of 06/10/2021)

About ADVANZ PHARMA Stock (OTCMKTS:CXRXF)

Key Stats

Today's Range
$17.06
$17.06
50-Day Range
$17.06
$17.06
52-Week Range
$2.13
$18.00
Volume
39 shs
Average Volume
11,851 shs
Market Capitalization
$834.46 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

ADVANZ PHARMA Corp. Limited, a pharmaceutical company, through its subsidiaries, owns or licenses a portfolio of branded and generic prescription products worldwide. The company operates through two segments: ADVANZ PHARMA International and ADVANZ PHARMA North America. Its ADVANZ PHARMA International segment offers a portfolio of branded and generic prescription products to wholesalers, distributors, hospitals, and pharmacies. This segment's products include Brinavess for the conversion of onset atrial fibrillation to sinus rhythm in adults; Aggrastat, a reversible GP IIb/IIIa inhibitor indicated for use in patients with acute coronary syndrome; Xydalba, a semi-synthetic lipoglycopeptide for the treatment of acute bacterial skin and skin structure infections in adults; and Zevtera/Mabelio, a cephalosporin antibiotic for the treatment of community-acquired and hospital-acquired pneumonia. The company's ADVANZ PHARMA North America segment provides Donnatal for the treatment of irritable bowel syndrome; Zonegran for the treatment of partial seizures in adults with epilepsy; Nilandron for the treatment of metastatic prostate cancer; Lanoxin for the treatment of mild to moderate heart failure and atrial fibrillation; Plaquenil for the treatment of lupus and rheumatoid arthritis; and Photofrin for the treatment of certain types of cancer. It also offers Prostaglandin E1 formulations for the treatment of erectile dysfunction and peripheral arterial occlusive disease under the Prostavasin, Viridal, Vasaprostan, and Edex brands, as well as holds licensed commercialization rights to a pre-registration drug/device combination product, Trevyent for the treatment of pulmonary arterial hypertension. It sells its products through direct sales and local distribution relationships. The company was formerly known as ADVANZ PHARMA Corp. and changed its name to ADVANZ PHARMA Corp. Limited in December 2019. ADVANZ PHARMA Corp. Limited is headquartered in London, the United Kingdom.

Receive CXRXF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ADVANZ PHARMA and its competitors with MarketBeat's FREE daily newsletter.

CXRXF Stock News Headlines

PHAT Phathom Pharmaceuticals, Inc.
The real reason Elon is fully endorsing Trump
Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump.
See More Headlines

CXRXF Stock Analysis - Frequently Asked Questions

ADVANZ PHARMA's stock was trading at $17.06 at the beginning of the year. Since then, CXRXF stock has increased by 0.0% and is now trading at $17.06.
View the best growth stocks for 2024 here
.

Shares of CXRXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:CXRXF
CIK
N/A
Fax
N/A
Employees
429
Year Founded
N/A

Profitability

Net Income
$-74,860,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$525.58 million
Book Value
$0.16 per share

Miscellaneous

Free Float
N/A
Market Cap
$834.46 million
Optionable
Not Optionable
Beta
N/A
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (OTCMKTS:CXRXF) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners